In 2021, IXS continued to develop a standardized product portfolio designed to fit market needs. In addition to the launch of new x-ray systems releases (Cougar & Cheetah EVO, FF20/35/85 CT, MTIS, UX20), this was reflected in a focus of R&D investment on the high-growth, high-margin semiconductor and electronics sector. This market offers great opportunities for the division. Executing on the focus strategy, IXS was able to reduce the number of customer-specific systems from thirteen to two, the number of software platforms from seven to three, and the number of distribution partners from over 300 to 50.

Despite the demands placed on the team by the restructuring measures, the division was able to ensure customer satisfaction and kept pace with the increasing market demand. A highlight of the year was the first win of an order with the new FF 35 Semi system for testing advanced packages. The division successfully won business with one of the largest device foundries in Taiwan, a top-five OSAT company (a provider of outsourced semiconductor assembly and testing). In order to be successful in this market, it is also necessary to use the latest 3D visualization and analysis software for extremely demanding 2D/3D imaging tasks. In close collaboration with ORS, a specialist in AI-based image processing that became part of the Comet Group at the end of 2020, IXS has developed a solution that enables customers to detect defects in such advanced packages faster and with greater reliability.